FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to pharmaceutics, namely to an aqueous pharmaceutical composition containing insulin, an insulin analogue or an insulin derivative and methionine; as well as to a method for preparing and using it for treating diabetes mellitus, and to a therapeutic agent for treating diabetes mellitus.
EFFECT: group of inventions provide stability of the above proteins in solution.
29 cl, 10 ex, 6 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL INSULIN DERIVATIVES WITH STRONGLY SLOWED PROFILE TIME/ACTION | 2009 |
|
RU2529952C2 |
| NOVEL INSULIN DERIVATIVES WITH EXTREMELY DELAYED TIME/ACTION PROFILE | 2009 |
|
RU2524423C2 |
| COMBINATION OF INSULIN AND GLP-1 AGONIST | 2014 |
|
RU2682671C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING AGONIST GLP-1, INSULIN AND METHIONINE | 2010 |
|
RU2537239C2 |
| COMBINATION OF INSULIN AND GLP-1 AGONIST | 2009 |
|
RU2532378C2 |
| DRUG IDENTIFICATION SYSTEM FOR INJECTION DEVICES WITH MULTIPLE DOSES | 2010 |
|
RU2533985C2 |
| PISTON FOR CARTRIDGE AND PISTON ROD FOR DEVICE FOR MEDICATION DELIVERY | 2010 |
|
RU2552887C2 |
| INJECTION DEVICE | 2014 |
|
RU2675685C2 |
| ACTUATING MECHANISM FOR DRUG DELIVERY DEVICE AND DRUG DELIVERY DEVICE | 2011 |
|
RU2577243C2 |
| ACTUATING MECHANISM FOR DRUG DELIVERY DEVICE AND DRUG DELIVERY DEVICE | 2011 |
|
RU2577451C2 |
